Mr. Paul Meister has been the Chairman of the Board since August 2019. Previously, he is a partner in Novalis LifeSciences LLC and is co-founder and Chief Executive Officer of Liberty Lane Partners, LLC. Before this, Mr. Meister served as a President of MacAndrews & Forbes Incorporated. Prior to this, he served, on an interim basis, as Executive Vice Chairman of Revlon, Inc. since 2018 and acted as Revlon’s principal executive officer. He also served as Chairman and Chief Executive Officer of inVentiv Health (now Syneos Health) since 2010 to 2014. Before this, he served as Chairman of Thermo Fisher Scientific, Inc., from November 2006 to April 2007. Prior to this, he served as an executive officer of Fisher Scientific International, Inc., from 1991 to 2006.

Mr. Chirag Patel has been the Co-Chief Executive Officer, President and Director of the Company since 2019. Previously, he served as a Co-Chairman of the Board from May 2018 to August 2019. Prior to this, he was Co-Founder of Amneal and served as Co-Chairman and Co-Chief Executive Officer of Amneal from 2005 to October 2017. He also serves as a Managing Trustee for the Liberty Science Center of New Jersey.

Mr Chintu Patel has been the Co-Chief Executive Officer, and Director of the Company since August 2019. Previously, he served as a Co-Chairman of the Board from May 2018 to August 2019. Before this, he served as Co-Chairman and Co-Chief Executive Officer of Amneal from 2002 until the Combination. He also served as co-founded. Prior to this, he served as pharmacist and senior-level manager with Eckerd Pharmacy since 1994 to 2002.

Mr. Tasos Konidaris is the Chief Financial Officer and Executive Vice President of the company. Prior to this, he served as Chief Financial Officer in Alcresta Therapeutics, Inc.’s from 2016 to 2020. Before this, he served as Executive Vice President, Chief Financial Officer and Head of Corporate Development of Ikaria, Inc., from 2011 to 2015. Prior to this, he served as Senior Vice President and Chief Financial Officer of Dun & Bradstreet Corporation. He currently serves as a Director on the boards of Kadmon Holdings and Zep Inc.

Mr. Jason B. Daly has been the Senior Vice President, Chief Legal Officer and Corporate Secretary since 2022. Before this, he served as Senior Vice President, U.S. Market Access and previously as Vice President & Chief of Staff, North American Commercial as well as General Counsel in U.S. Generics & North American Commercial. Prior to Teva, he served as served in various legal and commercial leadership roles with Straumann Group. Previously, he worked for law firms HinckleyAllen LLP and WilmerHale LLP.